giovedì, 3 ottobre 2024

Notizie AIOM – anno XV

19 Dicembre 2017

Impact of prediagnostic smoking and smoking cessation on colorectal cancer prognosis: a meta-analysis of individual patient data from cohorts within the CHANCES consortium

Smoking has been associated with colorectal cancer (CRC) incidence and mortality in previous studies and might also be associated with prognosis after CRC diagnosis. However, current evidence on smoking in association with CRC prognosis is limited. For this individual patient ...
Leggi tutto

18 Dicembre 2017

Statement from FDA Commissioner Scott Gottlieb, M.D., on new FDA efforts to support more efficient development of targeted therapies

December 15, 2017 - In recent years, the medical community has experienced a shift in the way health care is practiced. Rather than focusing solely on how to treat an overall disease type, medical innovators are now exploring how to tailor treatments that target unique characteristics ...
Leggi tutto

18 Dicembre 2017

EMA Management Board: highlights of December 2017 meeting

December 15, 2017 - The Management Board of the European Medicines Agency (EMA) heard from Executive Director Guido Rasi and Deputy Executive Director Noël Wathion how the Agency is preparing for relocation to Amsterdam in the Netherlands, and operationally for the ...
Leggi tutto

18 Dicembre 2017

European Commission closes infringement procedure against Roche

December 15, 2017 - The European Commission has announced that it has closed the infringement procedure taken against Roche for failure to meet certain pharmacovigilance obligations. The Commission explained that after considering all the available evidence and being satisfied ...
Leggi tutto

18 Dicembre 2017

Modified-release paracetamol-containing products to be suspended from EU market

December 15, 2017 - The CMDh has endorsed by majority a European Medicines Agency recommendation to suspend marketing of modified- or prolonged-release products containing paracetamol (designed to release paracetamol slowly over a longer period than the usual immediate-release ...
Leggi tutto

18 Dicembre 2017

15 dicembre 2017 – Comunicazione EMA su Paracetamolo a rilascio modificato

18 Dicembre 2017

NICE Recommends Ibrutinib for Relapsed/Refractory MCL

December 15, 2017 - The United Kingdom's National Institute for Health Care and Excellence (NICE) has published new guidelines recommending ibrutinib as treatment for patients with relapsed/refractory mantle cell lymphoma (MCL). The BTK inhibitor is approved for patients ...
Leggi tutto

15 Dicembre 2017

ASCO Clinical Practice Guideline Update: Use of Larynx-Preservation Strategies in the Treatment of Laryngeal Cancer

December 8, 2017 - As reported in the Journal of Clinical Oncology by Arlene A. Forastiere, MD, of The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, and colleagues, ASCO has issued a clinical practice guideline update on the use of larynx-preservation strategies ...
Leggi tutto

15 Dicembre 2017

FDA Grants Priority Review to Pembrolizumab for Relapsed/Refractory PMBCL

December 11, 2017 - The FDA has granted a priority review to a supplemental biologics license application (sBLA) for pembrolizumab as a treatment for adult and pediatric patients with relapsed/refractory primary mediastinal large B-cell lymphoma (PMBCL). Merck, the manufacturer ...
Leggi tutto

15 Dicembre 2017

FDA Grants Nivolumab/Ipilimumab Priority Review for RCC

December 14, 2017 - The FDA has granted a priority review to a supplemental biologics license application (sBLA) for use of the combination of nivolumab and ipilimumab as a frontline treatment for intermediate- and poor-risk patients with advanced renal cell carcinoma (RCC). ...
Leggi tutto